600.05 Comparative Efficacy, Durability and Safety of Olpasiran, Zerlasiran and Lepodisiran For Lipoprotein (a) Reduction: A Network Meta-Analysis

JACC: Cardiovascular Interventions 2026

View at publisher

Authors: Neel Parikh, Nimra Shafi, Meet Kachhadia, Neel Doshi, Sannidhya Singh, Snigdha Baddepudi, Sharan Mavani, Victor O. Adedara

DOI: 10.1016/j.jcin.2026.01.194

Cited by: 0

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Atherosclerosis and Cardiovascular Diseases